NCT07575074

Brief Summary

The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2026

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 8, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

May 15, 2026

Expected
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2026

Last Updated

May 8, 2026

Status Verified

May 1, 2026

Enrollment Period

3 months

First QC Date

February 22, 2026

Last Update Submit

May 4, 2026

Conditions

Keywords

Balancegaze stabilitymotion sicknessoptokinetic training

Outcome Measures

Primary Outcomes (4)

  • Motion sickness susceptibility questionnaire

    The Motion Sickness Susceptibility Questionnaire (MSSQ) is a widely used tool that assesses an individual's predisposition to motion sickness in various environments, such as vehicles, amusement rides, and virtual reality.

    8th week

  • Berg balance scale

    The Berg Balance Scale (BBS) is a reliable clinical tool used to assess balance in individuals, particularly older adults and those with balance impairments. It includes 14 tasks each scored from 0 (cannot perform) to 4 (performs independently). The BBS has a maximum score of 56, and most of the patients show a low fall risk of 41 to 56 scores, medium risk of 21 to 40 scores, and a high risk of 0 to 20 scores.

    8th week

  • Dynamic visual acuity test for gaze stability

    The Dynamic Visual Acuity (DVA) Test is a widely used clinical test to assess gaze stability, particularly in individuals with vestibular dysfunction. It evaluates a person's ability to maintain clear vision during head movements, which requires stable gaze control. The test involves reading porotype letters or symbols displayed on a screen, first in a stationary position and then while moving the head horizontally and vertically at a standardized speed (usually around 2 Hz)

    8th week

  • Head impulse test

    The Head Impulse Test (HIT) is a diagnostic tool used to evaluate the function of the vestibulo-ocular reflex (VOR), essential for maintaining gaze stability during rapid head movements. In this test, a clinician rapidly and unpredictably turns the patient's head to the left or right while the patient focuses on a stationary target, typically the clinician's nose. For a healthy VOR, the eyes should remain fixed on the target despite the head movement

    8th week

Study Arms (2)

Group A Habituation exercises

EXPERIMENTAL

Group A performed a regime of Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness

Other: Group A Habituation exercises

Group B Optokinetic training protocol

EXPERIMENTAL

Group B underwent a structured optokinetic training protocol combined with postural stabilization and gaze stability exercises, targeting both gaze and postural control systems.

Other: Group B Optokinetic training protocol

Interventions

Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness (38). Each session, lasting approximately 20-25 minutes, involved exercises conducted for 20 minutes per day, five times a week. Each session, lasting approximately 30-45 minutes, included low-intensity breathing exercises aimed at promoting relaxation and moderate-intensity aerobic activities, such as walking or cycling, at 50-60% of the participant's maximum heart rate.

Group A Habituation exercises

10-minute warm-up, followed by 20-25 minutes of moderate-intensity optokinetic exercises (viewing controlled moving visual patterns), postural exercises involving controlled head and body movements to engage the vestibular system, and gaze stability exercises, which require focusing on a stationary target during head movements to improve the vestibulo-ocular reflex. The session concluded with a 10-15-minute cool-down to aid relaxation. These sessions continued for 12 weeks

Group B Optokinetic training protocol

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients age 20 and 40 years
  • Passengers who have motion sickness during travelling
  • Patients of vestibular migraine who experience motion sickness
  • Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months

You may not qualify if:

  • Patients who have seasickness and simulator sickness excluded.
  • Patients having vestibular disease and chronic neurological disease.
  • Participants who have completed formal vestibular rehabilitation in last 6 months excluded
  • Patients with severe visual impairments and orthopedic conditions excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ittefaq Hospital Lahore

Lahore, Punjab Province, 54500, Pakistan

Location

MeSH Terms

Conditions

Vestibular DiseasesMotion Sickness

Condition Hierarchy (Ancestors)

Labyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Javeria Ghazal, MSNMPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 22, 2026

First Posted

May 8, 2026

Study Start (Estimated)

May 15, 2026

Primary Completion (Estimated)

August 15, 2026

Study Completion (Estimated)

September 14, 2026

Last Updated

May 8, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations